Raphael G Banoub1,2,3, Katie M Phillips2,3, Lloyd P Hoehle2,3, David S Caradonna2,4, Stacey T Gray2,3, Ahmad R Sedaghat2,3,4,5. 1. Wayne State University School of Medicine, Detroit, Michigan, U.S.A. 2. Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, U.S.A. 3. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, U.S.A. 4. Division of Otolaryngology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, U.S.A. 5. Department of Otolaryngology and Communications Enhancement, Boston Children's Hospital, Boston, Massachussetts, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: To determine the association between the frequency of acute chronic rhinosinusitis (CRS) exacerbations (AECRS) and the degree of asthma control in asthmatic CRS patients. STUDY DESIGN: Cross-sectional study. METHODS: We prospectively recruited 108 asthmatic CRS patients as participants. Asthma control was assessed using the Asthma Control Test (ACT). The frequency of AECRS was assessed using three previously described indirect metrics for AECRS: the frequency of patient-reported sinus infections, CRS-related antibiotics use, and CRS-related oral corticosteroids use in the last 3 months. CRS symptom severity was measured using the 22-item Sinonasal Outcome Test (SNOT-22). Associations between ACT score and metrics for AECRS were performed using linear regression while controlling for clinical and demographic characteristics, including SNOT-22 score. RESULTS: ACT score was significantly and negatively associated with the frequency of patient-reported sinus infections (adjusted linear regression coefficient [β] = -1.2, 95% confidence interval [CI]: -2.3 to -0.1, P = .033), CRS-related antibiotics courses (adjusted β = -1.4, 95% CI: -2.3 to -0.5, P = .004), and CRS-related oral corticosteroid courses (adjusted β = -1.5, 95% CI: -2.5 to -0.5, P = .004) in the last 3 months, independent of characteristics including SNOT-22 score. Poor asthma control could be detected using one or more sinus infections (70.6% sensitivity, 47.3% specificity), CRS-related antibiotics (50.0% sensitivity, 73.0% specificity), or CRS-related oral corticosteroids (58.8% sensitivity, 71.6% specificity) in the last 3 months. CONCLUSIONS: AECRS are negatively associated with the level of asthma control in asthmatic CRS patients, independent of CRS symptom severity. These results highlight AECRS as a distinct clinical manifestation of CRS that should be routinely assessed in CRS patients. LEVEL OF EVIDENCE: 2c. Laryngoscope, 128:1033-1038, 2018.
OBJECTIVES/HYPOTHESIS: To determine the association between the frequency of acute chronic rhinosinusitis (CRS) exacerbations (AECRS) and the degree of asthma control in asthmatic CRSpatients. STUDY DESIGN: Cross-sectional study. METHODS: We prospectively recruited 108 asthmatic CRSpatients as participants. Asthma control was assessed using the Asthma Control Test (ACT). The frequency of AECRS was assessed using three previously described indirect metrics for AECRS: the frequency of patient-reported sinus infections, CRS-related antibiotics use, and CRS-related oral corticosteroids use in the last 3 months. CRS symptom severity was measured using the 22-item Sinonasal Outcome Test (SNOT-22). Associations between ACT score and metrics for AECRS were performed using linear regression while controlling for clinical and demographic characteristics, including SNOT-22 score. RESULTS: ACT score was significantly and negatively associated with the frequency of patient-reported sinus infections (adjusted linear regression coefficient [β] = -1.2, 95% confidence interval [CI]: -2.3 to -0.1, P = .033), CRS-related antibiotics courses (adjusted β = -1.4, 95% CI: -2.3 to -0.5, P = .004), and CRS-related oral corticosteroid courses (adjusted β = -1.5, 95% CI: -2.5 to -0.5, P = .004) in the last 3 months, independent of characteristics including SNOT-22 score. Poor asthma control could be detected using one or more sinus infections (70.6% sensitivity, 47.3% specificity), CRS-related antibiotics (50.0% sensitivity, 73.0% specificity), or CRS-related oral corticosteroids (58.8% sensitivity, 71.6% specificity) in the last 3 months. CONCLUSIONS: AECRS are negatively associated with the level of asthma control in asthmatic CRSpatients, independent of CRS symptom severity. These results highlight AECRS as a distinct clinical manifestation of CRS that should be routinely assessed in CRSpatients. LEVEL OF EVIDENCE: 2c. Laryngoscope, 128:1033-1038, 2018.
Authors: Rehab Talat; Katie M Phillips; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat Journal: Eur Arch Otorhinolaryngol Date: 2019-07-15 Impact factor: 2.503
Authors: Claire Gleadhill; Marlene M Speth; Isabelle Gengler; Katie M Phillips; Lloyd P Hoehle; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat Journal: Eur Arch Otorhinolaryngol Date: 2020-08-04 Impact factor: 2.503
Authors: Jason H Kwah; Shaan N Somani; Whitney W Stevens; Robert C Kern; Stephanie S Smith; Kevin C Welch; David B Conley; Bruce K Tan; Leslie C Grammer; Amy Yang; Robert P Schleimer; Anju T Peters Journal: J Allergy Clin Immunol Date: 2020-01-29 Impact factor: 10.793
Authors: Gayatri B Patel; Elizabeth A Kudlaty; Amina Guo; Chen Yeh; Margaret S Kim; Caroline P E Price; David Conley; Leslie C Grammer; Ravi Kalhan; Robert C Kern; Kris G McGrath; Bruce K Tan; Sharon R Rosenberg; Robert P Schleimer; Stephanie S Smith; Whitney W Stevens; Kevin C Welch; Anju T Peters Journal: Allergy Asthma Proc Date: 2021-09-01 Impact factor: 2.587
Authors: S V Krasilnikova; E V Tush; P A Frolov; D Yu Ovsyannikov; A B Terentyeva; N I Kubysheva; T I Eliseeva Journal: Sovrem Tekhnologii Med Date: 2020-10-28
Authors: David T Liu; Martin Schally; Sven Schneider; Julia Eckl-Dorna; Katie M Phillips; Christian A Mueller; Ahmad R Sedaghat; Gerold Besser Journal: Eur Arch Otorhinolaryngol Date: 2021-04-20 Impact factor: 2.503